Government launches Drug Discovery Hackathon 2020


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Government launches Drug Discovery Hackathon 2020
Government launches Drug Discovery Hackathon 2020 (DDH2020), a first of its kind National Initiative for supporting drug discovery process

The Union Government launched Drug Discovery Hackathon here today in the presence of Union Minister for Science and Technology Dr. Harsh Vardhan and Union Minister for Human Resource Development Shri Ramesh Pokhriyal ‘Nishank’. This Drug Discovery Hackathon is a joint initiative of MHRD’s Innovation Cell (MIC), All India Council for Technical Education (AICTE) and Council of Scientific and Industrial Research (CSIR) and supported by Centre for Development of Advanced Computing (CDAC), MyGov as well as private players.

 Minister of State for HRD Shri Sanjay Dhotre, Principal Scientific Advisor Prof. Vijay Raghavan, DG CSIR, Dr.Shekhar Mande, Chairman AICTE, Prof. Anil Sahasrabudhe, President, Pharmacy Council of India (PCI) Prof. B Suresh and Chief Innovation Officer, MHRD, Dr. Abhay Jere were also present during the online launch program.

This Hackathon is first of its kind National initiative for supporting the drug discovery process and will see participation from professionals, faculty, researchers and students from varied fields like Computer Science, Chemistry, Pharmacy, Medical Sciences, Basic Sciences and Biotechnology.

Dr. Harsh Vardhan, Minister for S&T said, “We need to establish the culture of Computational Drug Discovery in our country. In this initiative, MHRD’s Innovation cell and AICTE will focus on identifying potential drug molecules through the Hackathon while CSIR will take these identified molecules forward for synthesis and laboratory testing for efficacy, toxicity, sensitivity and specificity.” Pointing out that drug discovery is a complex, expensive, arduous and time-consuming process, he added, “While we pursue clinical trials of few repurposed drugs for COVID-19, as they are faster and can quickly be launched, it is also important that we find other suitable repurposed drugs while at the same time continue working on new drug discovery to develop specific drugs against COVID-19”. He also stated, “in-silico drug discovery which utilizes Computational methods such as Machine Learning (ML), AI and Big Data will help in accelerating this process”.

Shri Ramesh Pokhriyal ‘Nishank’, HRD Minister said, “MHRD and AICTE have huge experience in organizing Hackathons but for the first time, we are using the hackathon model for tackling a great scientific challenge. More importantly, this initiative is open for researchers/faculty across the globe as we are keen on attracting international talent to join and support our efforts.”

Minister of State for HRD Shri Sanjay Dhotre also appreciated the concept and said, “Our government has kick-started Hackathon culture in this country which is very critical for challenging our youngsters to solve some of the daunting problems faced by our nation.”

Prof K. VijayRaghavan, PSA, Govt. of India said, “I wish to thank MHRD, AICTE and CSIR and all our partners for supporting this Hackathon which will help India establish a new model for expediting drug discovery process. The Hackathon consists of challenges that are posted as problem statements and, are based on specific drug discovery topics which, are open to the participants to solve. It will have three phases of three months each and the whole exercise is to be completed by April-May 2021. At the end of each phase, successful teams will be rewarded. The ‘lead’ compounds identified at the end of phase 3 will be taken forward for the experimental level at CSIR and other interested organizations.

During the launch function, Dr.Abhay Jere, Chief Innovation Officer explained the concept of Drug Discovery Hackathon, while Prof. Anil Sahasrabudhe extended all the support from AICTE and appealed all technical institutions to participate in this initiative in big numbers. Dr.Shekhar Mande extended all the required commitment from CSIR’s side for this initiative. He also expressed satisfaction with the quality and variety of problem statements released today.

 

Background Information and Methodology of Hackathon

  •  The Hackathon consists of challenges that are posted as problem statements and, are based on specific drug discovery topics which, are open to the participants to solve. A total of 29 Problem Statements (PS) have been identified.
  •  MyGov portal is being used and any Indian student can participate.
  •  Professionals and researchers from anywhere in the world can participate.
  •  TheHackathon will have three Tracks. Track 1 will primarily deal with drug design for anti-COVID-19 hit/lead generation: this is done using tools such as molecular modeling, pharmacophore optimization, molecular docking, hit/lead optimization, etc.
  •  Track 2 will deal with designing/optimizing new tools and algorithms which will have an immense impact on expediting the process of in silico drug discovery.
  •  There is also a third track called “Moon shot “which allows for working on problems that are ‘out of the box’ nature.

 

Tags : #DrHarshVardhan #DrugDiscoveryHackathon2020 #CSIR #AICTE #MHRD #SanjayDhotre #RameshPokhriyal

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026
Prostate Health Awareness: What Every Indian Man Must Know About Early Detection and PreventionJuly 30, 2026
Why Young Indians Are Facing Heart Problems: Causes, Warning Signs, and What to DoJuly 30, 2026
FemCare brand Healthfab acquires 2 acres land in Andhra Pradhesh to launch 2nd manufacturing facility for period care range of products; to invest Rs 15 crore July 29, 2026
Geriatric Wellness: New Technologies for Aging in Place GracefullyJuly 29, 2026
Digital Eye Strain 2.0: Protecting Vision in the Era of Spatial ComputingJuly 29, 2026
Endometriosis Awareness in India: Understanding the Condition That Affects Millions of Women in SilenceJuly 29, 2026
Prediabetes: Understanding the Critical Warning Stage Before DiabetesJuly 29, 2026
The Role of Microbiome in Pediatric Health: A New Era of Child WellnessJuly 28, 2026
The Rise of Bio-Individualized Diets: Tailoring Nutrition to Your DNAJuly 28, 2026
Immuneel Therapeutics and THSTI Announce Strategic Partnership to Advance CAR-T Cell Therapy and Lentiviral Vector Manufacturing July 28, 2026
Differential Diagnosis of Acute Abdomen: Differentiating Surgical Emergencies from Gastrointestinal MimicsJuly 28, 2026
Management of Rheumatic Heart Disease in Developing Nations: Secondary Prophylaxis and Valve InterventionsJuly 28, 2026
Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Galderma introduces Sculptra® in India, ushering in a new era of regenerative aestheticsJuly 27, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026